Pacific released a research report on April 23 stating that it gave Australian and Chinese endoscopy (688212.SH) a purchase rating. The main reasons for the rating include: 1) the gradual release of high-end endoscopes and the increase in the penetration rate of tertiary hospitals; 2) the expansion of the sales team to increase the market promotion of high-end products, and the gross profit margin and net interest rate increased in 23; 3) the release of a new equity incentive plan in '23 to set long-term high growth targets. (Mainichi Keizai Shimbun)